Physicochemical Properties of Microbial Glycopolymers

Microbial Glycobiology

Volumn , Issue , 2010, Pages 759-779

  Brandenburg, Klaus ^a   Garidel, Patrick ^b   Gutsmann, Thomas ^a  

^a RESEARCH CENTER BORSTEL   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882832096     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-374546-0.00038-9     Document Type: Chapter

References (129)

1. Abalos A., Pinazo A., Infante M.R., Casals M., García F., Manresa A. Physicochemical and antimicrobial properties of new rhamnolipids produce by Pseudomonas aeruginosa AT10 from soybean oil refinery wastes. Langmuir 2001, 17:1367-1371.
2. Al-Tahhan R.A., Sandrin T.R., Boour A.A., Maier R.M. Rhamnolipid-induced removal of lipopolysaccharide from Pseudomonas aeruginosa: effect on cell surface properties and interaction with hydrophobic substrates. Appl. Environ. Microbiol. 2000, 66:3262-3268.
3. Andrä J., Rademann J., Koch M.H.J., Heine H., Zähringer U., Brandenburg K. Endotoxin-like properties of a rhamnolipid exotoxin from Burkholderia (Pseudomonas) plantarii: immune cell stimulation and biophysical characterization. Biol. Chem. 2006, 387:301-310.
4. Andrä J., Howe J., Garidel P., et al. Mechanism of interaction of optimized Limulus-derived cyclic peptides with endotoxins: thermodynamic, biophysical and microbiological analysis. Biochem. J. 2007, 406:297-307.
5. Aranda F.J., Espuny M.J., Marqués A., Teruel J.A., Manresa A., Ortiz A. Thermodynamics of the interaction of a dirhamnolipid biosurfactant secreted by Pseudomonas aeruginosa with phospholipid membranes. Langmuir 2007, 23:2700-2705.
6. Aspinall G.O., Chatterjee D., Brennan P.J. The variable surface glycolipids of mycobacteria: structures, synthesis of epitopes, and biological properties. Adv. Carbohydr. Chem. Biochem. 1995, 51:169-242.
7. Aurell C.A., Wistrom A.O. Critical aggregate concentration of Gram-negative bacterial lipopolysaccharides (LPS). Biochem. Biophys. Res. Commun. 1998, 253:119-123.
8. Axelrod S., Oschkinat H., Enders J., et al. Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide. Cell. Microbiol. 2008, 10:1530-1545.
9. Barrow W.W., Brennan P.J. Immunogenicity of type-specific C-mycoside glycopeptidolipids of mycobacteria. Infect. Immun. 1982, 36:678-684.
10. Benincasa M., Abalos A., Oliveira I., Manresa A. Chemical structure, surface properties and biological activities of the biosurfactant produced by Pseudomonas aeruginosa LBI from soapstock. Antonie van Leeuwenhoek 2004, 85:1-8.
11. Besra G.S., Khoo K.H., McNeil M.R., Dell A., Morris H.R., Brennan P.J. A new interpretation of the structure of the mycolyl-arabinogalactan complex of Mycobacterium tuberculosis as revealed through characterization of oligoglycosylalditol fragments by fast-atom bombardment mass spectrometry and 1H nuclear magnetic resonance spectroscopy. Biochemistry 1995, 34:4257-4266.
12. + channel in transmembrane signaling. J. Immunol. 2001, 166:1009-1015.
13. Brandenburg K., Seydel U. Physical aspects of structure and function of membranes made from lipopolysaccharides and free lipid A. Biochim. Biophys. Acta 1984, 775:225-238.
14. Brandenburg K., Seydel U. Investigation into the fluidity of lipopolysaccharide and free lipid A membrane systems by Fourier-transform infrared spectroscopy and differential scanninig calorimetry. Eur. J. Biochem. 1990, 191:229-236.
15. Brandenburg K., Koch M.H.J., Seydel U. Phase diagram of lipid A from Salmonella minnesota and Escherichia coli rough mutant lipopolysaccharide. J. Struct. Biol. 1990, 105:11-21.
16. Brandenburg K., Koch M.H.J., Seydel U. Phase diagram of deep rough mutant lipopolysaccharide from Salmonella minnesota R595. J. Struct. Biol. 1992, 108:93-106.
17. Brandenburg K., Mayer H., Koch M.H.J., Weckesser J., Rietschel E.Th., Seydel U. Influence of the supramolecular structure of free lipid A on its biological activity. Eur. J. Biochem. 1993, 218:555-563.
18. Brandenburg K., Kusumoto S., Seydel U. Conformational studies of synthetic lipid A analogues and partial structures by infrared spectroscopy. Biochim. Biophys. Acta 1997, 1329:193-201.
19. II structures of lipid A from Salmonella enterica serovar Minnesota by X-ray diffraction and freeze-fracture electron microscopy. Chem. Phys. Lipids 1998, 91:53-69.
20. Brandenburg K., Matsuura M., Heine H., et al. Biophysical characterisation of triacyl monosaccharide lipid A partial structures in relation to bioactivity. Biophys. J. 2002, 83:322-333.
21. Brandenburg K., Andrä J., Müller M., Koch M.H.J., Garidel P. Physicochemical properties of bacterial glycopolymers in relation to bioactivity. Carbohydr. Res. 2003, 338:2477-2489.
22. Brandenburg K., Hawkins L., Garidel P., et al. Structural polymorphism and endotoxic activity of synthetic phospholipid-like amphiphiles. Biochemistry 2004, 43:4039-4046.
23. Brennan P.J. Structure, function, and biogenesis of the cell wall of Mycobacterium tuberculosis. Tuberculosis 2003, 83:91-97.
24. Champion J.T., Gilkey J.C., Lamparski H., Retterer J., Niller R.M. Electron microscopy of rhamnolipid (biosurfactant) morphology: effects of pH, cadmium, and octadecane. J. Colloid Interface Sci. 1995, 170:569-574.
25. Chatterjee D., Bozic C.M., McNeil M., Brennan P.J. Structural features of the arabinan component of the lipoarabinomannan of Mycobacterium tuberculosis. J. Biol. Chem. 1991, 266:652-660.
26. Chatterjee D., Lowell K., Rivoire B., McNeil M.R., Brennan P.J. Lipidoarabinomannan of Mycobacterium tuberculosis. Capping with mannosyl residues in some strains. J. Biol. Chem. 1992, 267:6234-6239.
27. Chatterjee D., Khoo K.H., McNeil M.R., Dell A., Morris H.R., Brennan P.J. Structural definition of the non-reducing termini of mannose-capped LAM from Mycobacterium tuberculosis through selective enzymatic degradation and fast atom bombardment-mass spectrometry. Glycobiology 1993, 3:497-506.
28. Chen G. Rhamnolipid biosurfactant behavior in solutions. J. Biomat. Sci. Polymer Ed. 2004, 15:229-235.
29. Chen X., Howe J., Andra J., et al. Biophysical analysis of the interaction of granulysin-derived peptides with enterobacterial endotoxins. Biochim. Biophys. Acta 2007, 1768:2421-2431.
30. Choe B.Y., Krishna N.R., Pritchard D.G. Proton NMR study on rhamnolipids produced by Pseudomonas aeruginosa. Magn. Reson. Chem. 1992, 30:1025-1026.
31. Chua J., Vernge I., Master S., Deretic V. A tale of two lipids: Mycobacterium tuberculosis phagosome maturation arrest. Curr. Opin. Microbiol. 2004, 7:71-77.
32. Cohen R., Exerowa D. Surface forces and properties of foam films from rhamnolipid biosurfactants. Adv. Colloid Interf. Sci. 2007, 134-135:24-34.
33. Cohen R., Ozdemir G., Exerowa D. Free thin liquid films (foam films) from rhamnolipids: type of the film and stability. Coll. Surf. B. 2003, 29:197-204.
34. Cohen R., Exerowa D., Pigov I., Heckmann R., Lang S. DLVO and non-DLVO forces in thin liquid fils from rhamnolipids. J. Adhesion 2004, 80:875-894.
35. Cossins A.R., Sinensky M. Adaptation of membranes to temperature, pressure, and exogeneous lipids. Physiology of Membrane Fluidity 1984, 1-20. CRC Press, Boca Raton. M. Shinitzky (Ed.).
36. Curatolo W. Glycolipid function. Biochim. Biophys. Acta 1987, 906:137-160.
37. Daffé M., Laneelle M.A., Puzo G. Structural elucidation by field desorption and electron-impact mass spectrometry of the C-mycosides isolated from Mycobacterium smegmatis. Biochim. Biophys. Acta 1983, 751:439-443.
38. Dahrazma B., Mulligan C.N., Nieh M.-P. Effects of additives on the structure of rhamnolipid (biosurfactant): a small-angle neutron scattering (SANS) study. J. Colloid Interf. Sci. 2008, 319:590-593.
39. Dao D.N., Kremer L., Guerardel Y., et al. Mycobacterium tuberculosis lipomannan induces apoptosis and interleukin-12 production in macrophages. Infect. Immun. 2004, 72:2067-2074.
40. Desai J.D., Banat I.M. Microbial production of surfactants and their commercial potential. Microb. Molec. Biol. Rev. 1997, 61:47-64.
41. Elass E., Codeville B., Guerardel Y., et al. Identification by surface plasmon resonance of the mycobacterial lipomannan and lipoarabinomannan domains involved in binding to CD14 and LPS-binding protein. FEBS Lett. 2007, 581:1383-1390.
42. Emons H., Werner G., Haferburg D., Kleber H.P. Tensammetric determination of a rhamnolipid at mercury electrodes. Electroanalysis 1989, 1:555-557.
43. Etienne G., Villeneuve C., Billman-Jacobe H., Astarie-Dequeker C., Dupont M.A., Daffe M. The impact of the absence of glycopeptidolipids on the ultrastructure, cell surface and cell wall properties, and phagocytosis of Mycobacterium smegmatis. Microbiology 2002, 148:3089-3100.
44. Frecer V., Ho B., Ding J.L. Molecular dynamics study on lipid A from Escherichia coli: insights into its mechanism of biological action. Biochim. Biophys. Acta 2000, 1466:87-104.
45. Fuijita Y., Naka T., McNeil M.R., Yano I. Intact molecular characterization of cord factor (trehalose 6,6′-dimycolate) from nine species of mycobacteria by MALDI-TOF mass spectrometry. Microbiology 2005, 151:3403-3416.
46. Garidel P., Hildebrand A., Neubert R., Blume A. Thermodynamic characterization of bile salt aggregation as a function of temperature and ionic strength using isothermal titration calorimetry. Langmuir 2000, 16:5267-5275.
47. Garidel P., Hildebrand A., Blume A. Understanding the self-organisation of colloidal systems. MicroCal Application Note 2004, 1-9.
48. Garidel P., Andrä J., Howe J., Gutsmann T., Brandenburg K. Novel anti-inflammatory and anti-infective agents. Anti-Infect. Agents Medic. Chem. 2007, 6:185-200.
49. Garidel P., Hildebrand A., Knauf K., Blume A. Membranolytic activity of bile salts: influence of biological membrane properties and composition. Molecules 2007, 12:2292-2326.
50. Gotoh K., Mitsuyama M., Imaizumi S., Kawamura I., Yano I. Mycolic acid-containing glycolipid as a possible virulence factor of Rhodococcus equi for mice. Microbiol. Immunol. 1991, 35:175-185.
51. Guérardel Y., Maes E., Elass E., et al. Structural study of lipomannan and lipoarabinomannan from Mycobacterium chelonae. Presence of unusual components with α1,3-mannopyranose side chains. J. Biol. Chem. 2002, 277:30635-30648.
52. Guerra-Santos L., Käppeli O., Fiechter A. Pseudomonas aeruginosa biosurfactant production in continuous culture with glucose as carbon source. Appl. Environm. Microbiol. 1984, 48:301-305.
53. Gutsmann T., Schromm A.B., Koch M.H.J., et al. Lipopolysaccharide-binding protein-mediated interaction of lipid A from different origin with phospholipid membranes. Phys. Chem. Chem. Phys. 2000, 2:4521-4528.
54. Gutsmann T., Schromm A.B., Brandenburg K. The physicochemistry of endotoxins in relation to bioactivity. Int. J. Med. Microbiol. 2007, 297:341-352.
55. Haba E., Abalos A., Jauregui O., Espuny M.J., Manresa A. Use of liquid chromatography-mass spectroscopy for studying the composition and properties of rhamnolipids produced by different strains of Pseudomonas aeruginosa. J. Surfact. Deterg. 2003, 6:155-161.
56. Haba E., Pinazo A., Jauregui O., Espuny M.J., Infante M.R., Manresa A. Physicochemical characterisation and antimicrobial properties of rhamnolipids produced by Pseudomonas aeruginosa 47T2 NCBIM 40044. Biotechnol. Bioeng. 2003, 81:316-322.
57. Harland C.W., Rabuka D., Bertozzi C.R., Parthasarathy R. The M. tuberculosis virulence factor trehalose dimycolate imparts desiccation resistance to model mycobacterial membranes. Biophys. J. 2008, 94:4718-4724.
58. Hauser G., Karnovsky L. Studies on the biosynthesis of L-rhamnose. J. Biol. Chem. 1959, 233:287-291.
59. Herman D.C., Zhang Y., Miller R.M. Rhamnolipid (biosurfactant) effects on cell aggregation and biodegradation of residual hexadecane under saturated flow conditions. Appl. Environ. Microbiol. 1997, 63:3622-3627.
60. Heyd M., Kohnert A., Tan T.H., et al. Development and trends of biosurfactant analysis and purification using rhamnolipids as an example. Analyt. Bioanalyt. Chem. 2008, 391:1579-1590.
61. Hildebrand A., Garidel P., Neubert R., Blume A. Thermodynamics of demicellisation of mixed micelles composed of sodium oleate and bile salts. Langmuir 2004, 20:320-328.
62. Holst O., Suesskind M., Grimmecke D., Brade L., Brade H. Core structures of enterobacterial lipopolysaccharides. Prog. Clin. Biol. Res. 1998, 397:23-35.
63. Howe J., Bauer J., Andra J., et al. Biophysical characterization of synthetic rhamnolipids. FEBS J. 2006, 273:5101-5112.
64. Howe J., Hammer M., Alexander C., et al. Biophysical characterization of the interaction of endotoxins with hemoglobins. Med. Chem. 2007, 3:13-20.
65. Hung H.C., Shreve G.S. Effect of the hydrocarbon phase on interfacial and thermodynamic properties of two anionic glycolipid biosurfactants in hydrocarbon/water systems. J. Phys. Chem. B 2001, 105:12596-12600.
66. Hunter S.W., Brennan P.J. Evidence for the presence of a phosphatidylinositol anchor on the lipoarabinomannan and lipomannan of Mycobacterium tuberculosis. J Biol. Chem. 1990, 265:272-279.
67. Ishigami Y. Characterisation of biosurfactants. Structure Performance Relationship in Surfactants 1997, 197-226. Dekker, New York. K. Esumi, M. Ueno (Eds.).
68. Ishigami Y., Gama Y., Nahahora H., Yamaguchi M., Nakahara H., Kamata T. The pH-sensitive conversion of molecular aggregates of rhamnolipid biosurfactant. Chem. Lett. 1987, 7:763-766.
69. Ishigami Y., Gama Y., Fumiyoshi I., Choi Y.K. Colloid chemical effect of polar head moieties of a rhamnolipid-type biosurfactant. Langmuir 1993, 9:1634-1636.
70. Israelachvili J.N. Intermolecular and Surface Forces 1991, Academic Press, London.
71. Jiao B., Freudenberg M., Galanos C. Characterization of the lipid A component of genuine smooth-form lipopolysaccharide. Eur. J. Biochem. 1989, 180:515-518.
72. Kano H., Doi T., Fujita Y., Takimoto H., Yano I., Kumazawa Y. Serotype-specific modulation of human monocyte functions by glycopeptidolipid (GPL) isolated from Mycobacterium avium complex. Biol. Pharm. Bull. 2005, 28:335-339.
73. Kastowsky M., Sabisch A., Gutberlet T., Bradaczek H. Molecular modelling of bacterial deep rough mutant lipopolysaccharide of Escherichia coli. Eur. J. Biochem. 1991, 197:707-716.
74. Kaufmann S.H. Protection against tuberculosis: cytokines, T cells, and macrophages. Annu. Rheum. Dis. 2002, 61(Suppl. 2):54-58.
75. Khoo K.H., Dell A., Morris H.R., Brennan P.J., Chatterjee D. Inositol phosphate capping of the nonreducing termini of lipoarabinomannan from rapidly growing strains of Mycobacterium. J. Biol. Chem. 1995, 270:12380-12389.
76. Khoo K.H., Jarboe E., Barker A., Torrelles J., Kuo C.D.W., Chatterjee D. Altered expression profile of the surface glycopeptidolipids in drug-resistant clinical isolates of Mycobacterium avium complex. J. Biol. Chem. 1999, 274:9778-9785.
77. Loppnow H., Flad H.-D., Rietschel E.Th., Brade H. The active principle of bacterial lipopolysaccharides (endotoxins) for cytokine induction. Pathophysiology of Shock, Sepsis, and Organ Failure 1993, 405-416. Springer-Verlag, Heidelberg. G. Schlag, H. Redl (Eds.).
78. Luzzati V., Mariani P., Gulik-Krzywicki T. The cubic phases of liquid-containing systems: physical structure and biological implications. Physics of Amphiphilic Layers 1987, vol. 21:131-137. Springer-Verlag, Berlin. J. Mennier, D. Langevin, N. Boccara (Eds.).
79. Mata-Sandoval J.C., Karns J., Torrents A. HPLC method for the characterization of rhamnolipids mixtures produced by Pseudomonas aeruginosa UG2 on corn oil. J. Chromatogr. A. 1999, 864:211-220.
80. Matsuura M., Kiso M., Hasegawa A. Activity of monosaccharide lipid A analogues in human monocytic cells as agonists or antagonists of bacterial lipopolysaccharide. Infect. Immun. 1999, 67:6286-6292.
81. Maurer N., Glatter O., Hofer M. Determination of size and structure of lipid IV a vesicles by quasi-elastic light scattering and small-angle X-ray scattering. J. Appl. Cryst. 1991, 24:832-835.
82. Mayer H., Krauss J.H., Yokota A., Weckesser J. Natural variants of lipid A. Endotoxin 1990, 45-70. Plenum Press, New York. H. Friedman, T.W. Klein, M. Nakano, A. Nowotny (Eds.).
83. Mueller M., Lindner B., Kusumoto S., Fukase K., Schromm A.B., Seydel U. Aggregates are the biologically active units of endotoxin. J. Biol. Chem. 2004, 279:26307-26313.
84. Mueller M., Brandenburg K., Dedrick R., Schromm A.B., Seydel U. Phospholipids inhibit lipopolysaccharide (LPS)-induced cell activation: a role for LPS-binding protein. J. Immunol. 2005, 174:1091-1096.
85. Mueller M., Lindner B., Dedrick R., Schromm A.B., Seydel U. Endotoxin: physical requirements for cell activation. J. Endotoxin. Res. 2005, 11:299-303.
86. Müller M., Scheel O., Lindner B., Gutsmann T., Seydel U. The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation. J. Endotoxin Res. 2002, 9:181-186.
87. Nakata T., Yasuda M., Fujita M., et al. CD14 directly binds to tri-acylated lipopeptides and facilitates recognition of the lipopeptides by the receptor complex of Toll-like receptors 2 and 1 without binding to the complex. Cell Microbiol. 2006, 8:1899-1909.
88. Nigou J., Zelle-Rieser C., Gilleron M., Thurnher M., Puzo G. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J. Immunol. 2001, 166:7477-7485.
89. 31P-NMR spectroscopic and microscopic investigations. Biophys. J. 2008, 95:1226-1238.
90. Özdemir G., Peker S., Helvaci S.S. Effect of pH on the surface and interfacial behaviour of rhamnolipids R1 and R2. Colloids Surf. A. 2004, 234:135-143.
91. Parra J.L., Guinea J., Manresa A., et al. Chemical characterization and physicochemical behavior of biosurfactants. J. Am. Oil Chem. Soc. 1989, 66:141-145.
92. Perfumo A., Banat I.M., Canganella F., Marchant R. Rhamnolipid production by a novel thermophilic hydrocarbon-degrading Pseudomonas aeruginosa AP02-1. Appl. Microbiol. Biotech. 2006, 72:132-138.
93. Puissegur M.P., Gilleron M., Botella L., et al. Mycobacterial lipomannan induces granuloma macrophage fusion via a TLR2-dependent, ADAM9- and β1 integrin-mediated pathway. J. Immunol. 2007, 178:3161-3169.
94. Rao V., Fuijiwara N., Porcelli S.A., Glickman M.S. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 2005, 201:535-543.
95. Rao V., Gao F., Chen B., Jacobs W.R., Glickman M.S. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J. Clin. Invest. 2006, 116:1660-1667.
96. Reichelt H., Faunce C.A., Paradies H.H. The phase diagram of charged colloidal lipid A-diphosphate dispersions. J. Phys. Chem. B 2008, 112:3290-3293.
97. Rendell N.B., Taylor G.W., Somerville M., Todd H., Wilson R., Coe P.J. Characterisation of Pseudomonas rhamnolipids. Biochim. Biophys. Acta 1990, 1045:189-193.
98. Rietschel E.Th., Galanos C., Tanaka A., Ruschmann E., Lüderitz O., Westphal O. Biological activities of chemically modified endotoxins. Eur. J. Biochem. 1971, 22:218-224.
99. Rietschel E.T., Brade L., Holst O., et al. Molecular structure of bacterial endotoxin in relation to bioactivity. Cellular and Molecular Aspects of Endotoxin Reactions 1990, 15-32. Elsevier Science Publishers, Amsterdam. A. Nowotny, J.J. Spitzer, E.J. Ziegler (Eds.).
100. Rietschel E.T., Brade H., Holst O., et al. Bacterial endotoxin: chemical constitution, biological recognition, host response, and immunological detoxification. Curr. Top. Microbiol. Immunol. 1996, 216:39-81.
101. Risco C., Carrascosa J.L., Bosch M.A. Visualization of lipopolysaccharide aggregates by freeze-fracture and negative staining. J. Electron. Microsc. 1993, 42:202-204.
102. Ryll R., Kumazawa Y., Yano I. Immunological properties of trehalose dimycolate (cord factor) and other mycolic acid-containing glycolipids. Microbiol. Immunol. 2001, 45:801-811.
103. Saavedra R., Segura E., Tenorio E.P., Lopez-Marin L.M. Mycobacterial trehalose-containing glycolipid with immunomodulatory activity on human CD4+ and CD8+ T-cells. Microbes Infect. 2006, 8:533-540.
104. Sánchez M., Teruel J.A., Espuny M.J., et al. Modu-lation of the physical properties of dielaidoylphosphatidylethanolamine membranes by a dirhamnolipid biosurfactant produced by Pseudomonas aeruginosa. Chem. Phys. Lipids 2006, 142:118-127.
105. Sánchez M., Aranda F.J., Espuny M.J., et al. Aggregation behaviour of a dirhamnolipid biosurfactant secreted by Pseudomonas aeruginosa in aqueous media. J. Colloid Interf. Sci. 2007, 307:246-253.
106. Sasaki H., White S.H. Aggregation behavior of an ultra-pure lipopolysaccharide (LPS) that stimulates TLR-4 receptors. Biophys. J. 2008, 95:986-993.
107. Schromm A.B., Brandenburg K., Loppnow H., et al. The charge of endotoxin molecules influences their conformation and interleukin-6 inducing capacity. J. Immunol. 1998, 161:5464-5471.
108. Schromm A.B., Brandenburg K., Loppnow H., et al. Biological activities of lipopolysaccharides are determined by the shape of their lipid A portion. Eur. J. Biochem. 2000, 267:2008-2013.
109. Schromm A.B., Howe J., Ulmer A.J., et al. Physicochemical and biological analysis of synthetic bacterial lipopeptides: validity of the concept of endotoxic conformation. J. Biol. Chem. 2007, 282:11030-11037.
110. Seydel U., Koch M.H.J., Brandenburg K. Structural polymorphisms of rough mutant lipopolysaccharides Rd to Ra from Salmonella minnesota. J. Struct. Biol. 1993, 110:232-243.
111. Seydel U., Ulmer A.J., Uhlig S., Rietschel E.Th. Lipopolysaccharide, a membrane-forming and inflammation-inducing bacterial macromolecule. Membrane Structure in Disease and Drug Therapy 2000, 217-251. Marcel Dekker Inc., New York. G. Zimmer (Ed.).
112. Seydel U., Oikawa M., Fukase K., Kusumoto S., Brandenburg K. Intrinsic conformation of lipid A is responsible for agonistic and antagonistic activity. Eur. J. Biochem. 2000, 267:3032-3039.
113. Seydel U., Hawkins L., Schromm A.B., et al. The generalized endotoxic principle. Eur. J. Immunol. 2003, 33:1586-1592.
114. Seydel U., Schromm A.B., Brade L., et al. Physicochemical characterization of carboxymethyl lipid A derivatives in relation to biological activity. FEBS J. 2005, 272:327-340.
115. Shands J.W. The physical structure of bacterial lipopolysaccharides. Microbial Toxins, Vol. IV: Bacterial Endotoxins 1971, 127-144. Academic Press, New York. G. Weinbaum, S. Kadis, S.J. Ajl (Eds.).
116. Shinitzky M. Membrane fluidity and cellular functions. Physiology of Membrane Fluidity 1984, 1-51. CRC Press, Boca Raton. M. Shinitzky (Ed.).
117. Simons M.P., Moore J.M., Kemp T.J., Griffith T.S. Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils. Infect. Immun. 2007, 75:1265-1271.
118. Soberén-Chávez G., Lépine F., Déziel E. Production of rhamnolipids by Pseudomonas aeruginosa. Appl. Microbiol. Biotech. 2005, 68:718-725.
119. Sotirova A.V., Spasova D.I., Galabova D.N., Karpenko E., Shulga A. Rhamnolipid-biosurfactant permeabilizing effects on Gram-positive and Gram-negative bacterial strains. Curr. Microbiol. 2008, 56:639-644.
120. Syldatk C., Lang S., Matulovic U., Wagner F. Production of four interfacial active rhamnolipids from n-alkanes or glycerol by resting cells of Pseudomonas species DSM 2874. Z. Naturforsch. 1985, 40c:61-67.
121. Takayama K., Din Z.Z., Mukerjee P., Cooke P.H., Kirkland T.N. Physicochemical properties of the lipopolysaccharide unit that activates B lymphocytes. J. Biol. Chem. 1990, 265:14023-14029.
122. Thanomsub B., Pumeechockchai W., Limtrakul A., et al. Chemical structures and biological activities of rhamnolipids produced by Pseudomonas aeruginosa B189 isolated from milk factory waste. Biores. Technol. 2007, 98:1149-1153.
123. Vignal C., Guérardel Y., Kremer L., et al. Lipomannans, but not lipoarabinomannans, purified from Mycobacterium chelonae and Mycobacterium kansasii induce TNF-α and IL-8 secretion by a CD14-toll-like receptor 2-dependent mechanism. J. Immunol. 2003, 171:2014-2023.
124. Villeneuve C., Gilleron M., Marídonneau-Parini I., Daffe M., Astarie-Dequeker C., Etienne G. Mycobacteria use their surface-exposed glycolipids to infect human macrophages through a receptor-dependent process. J. Lipid Research. 2005, 46:475-483.
125. Wilkinson S.G. Bacterial lipopolysaccharides - themes and variations. Prog. Lipid Res. 1996, 35:283-343.
126. York J.D., Firoozabadi A. Comparing effectiveness of rhamnolipid biosurfactant with a quaternary ammonium salt surfactant for hydrate anti-agglomeration. J. Phys. Chem. B. 2008, 112:845-851.
127. Zähringer U., Salvetzki R., Ulmer A.J., Rietschel E.Th. Isolation, chemical analysis and biological investigations of natural lipid A and lipid A-antagonists. J. Endotoxin Res. 1996, 3(Suppl. 1):33.
128. Zhong H., Zeng G., Yuan X.Z., Fu H.Y., Huang G.H., Ren F.Y. Adsorption of dirhamnolipid on four microorganisms and the effect on cell surface hydrophobicity. Appl. Microbiol. Biotechnol. 2007, 77:447-455.
129. Zulianello L., Canard C., Köhler T., Caille D., Lacroix J.S., Meda P. Rhamnolipids are virulence factors that promote early infiltration of primary human airway epithelia by Pseudomonas aeruginosa. Infect. Immunity 2006, 74:3134-3147.